Palivizumab (Palivizumab)
Overview of Palivizumab
Palivizumab is a monoclonal antibody used for the prevention of respiratory syncytial virus infection in infants at high risk of infection.
Indication of Palivizumab
Palivizumab is primarily indicated in conditions like Duodenal errosions.
Contraindication of Palivizumab
No data regarding the contra indications of Palivizumab is available.
Side Effects of Palivizumab
The symptomatic adverse reactions produced by Palivizumab are more or less tolerable and if they become severe, they can be treated symptomatically, these include Vomiting, Diarrhea, Fever, Nervousness, Rashes, Pain, Cough, Abnormal LFT, Rhinitis, Wheezing, Injection-site reactions, Leucopenia.
Precautions of Palivizumab
Palivizumab should be used with caution in moderate to severe acute infection or febrile illness; congenital heart disease; thrombocytopenia. Facilities for cardiopulmonary resuscitation must be at hand.